Tang Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300,000	Closed	-$8.01M	–	52
2025 Q4	$8.01M	Sell	300,000 -1,200,000	-80%	-$28.7M	0.4%	47
2025 Q3	$32M	Hold	1,500,000	–	–	1.23%	24
2025 Q2	$32.4M	Hold	1,500,000	–	–	1.64%	14
2025 Q1	$24.9M	Hold	1,500,000	–	–	1.38%	17
2024 Q4	$27.5M	Hold	1,500,000	–	–	1.82%	13
2024 Q3	$23.1M	Hold	1,500,000	–	–	1.65%	16
2024 Q2	$24.4M	Buy	1,500,000 +981,100	+189%	+$15.8M	2.48%	9
2024 Q1	$9.59M	Buy	518,900 +404,500	+354%	+$10M	1%	35
2023 Q4	$3.58M	Buy	114,400 +14,400	+14%	+$344K	0.33%	71
2023 Q3	$2.08M	Buy	+100,000	New	+$2.72M	0.29%	69